Umbhali: William Ramirez
Umhla Wokudalwa: 18 Eyomsintsi 2021
Hlaziya Umhla: 14 Eyenkanga 2024
Anonim
RESVERATROL & PTEROSTILBENE | Why I Stopped Taking Them
Ividiyo: RESVERATROL & PTEROSTILBENE | Why I Stopped Taking Them

Umxholo

I-Resveratrol yikhemikhali efumaneka kwiwayini ebomvu, izikhumba ezibomvu zamagilebhisi, ijusi yamagilebhisi emfusa, i-mulberries, kunye nexabiso elincinci kumanqatha. Isetyenziswa njengeyeza.

I-Resveratrol isetyenziswa kakhulu kwi-cholesterol ephezulu, umhlaza, isifo sentliziyo, kunye nezinye iimeko ezininzi. Nangona kunjalo, abukho ubungqina obuqinileyo bokuxhasa ukusetyenziswa kwe-resveratrol kwezi zinto zisetyenziswayo.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe ULAWULO OLUQHELEKILEYO zezi zilandelayo:

Inokwenzeka ukuba isebenze ...

  • Yewena mkhuhlane. Ukusebenzisa isitshizi sempumlo esine-resveratrol kathathu yonke imihla kwiiveki ezi-4 kubonakala ngathi kunciphisa iimpawu zokungabikho komzimba kubantu abadala abanamaxesha athile onyaka. Sebenzisa isitshizi sempumlo esine-resveratrol kunye ne-beta-glucans kathathu mihla le kwiinyanga ezi-2 kukwabonakala ngathi kunciphisa iimpawu zokungabikho komzimba kubantwana abanamaxesha athile onyaka.
  • Ukutyeba kakhulu. Olunye uphando lubonisa ukuba ukuthatha i-resveratrol kunokunyusa ukulahleka kwesisindo kubantu abadala abatyebe kakhulu.

Kusenokwenzeka ukuba ayisebenzi ...

  • Isifo sentliziyo. Abantu abadla ixabiso eliphezulu lokutya kwakhona akubonakali ngathi banomngcipheko ophantsi wesifo sentliziyo xa kuthelekiswa nabantu abasebenzisa imali encinci. Kwakhona, ukuthatha i-resveratrol ngomlomo akubonakali kuphucula amanqanaba e-cholesterol okanye amafutha egazi abizwa ngokuba yi-triglycerides kubantu abasengozini yesifo senhliziyo.
  • Ukuhlelwa kweempawu ezonyusa umngcipheko wesifo seswekile, isifo sentliziyo, kunye nokubetha (isifo se-metabolic syndrome). Ukuthatha i-resveratrol akubonakali ukwehlisa uxinzelelo lwegazi, iswekile yegazi, okanye icholesterol kubantu abane-metabolic syndrome. Uphando lwakwangoko lubonisa ukuba i-resveratrol inokunceda ukunciphisa ubunzima bomzimba kunye namafutha omzimba kubantu abane-metabolic syndrome. Kodwa kufuneka uphando olungakumbi ukuze kuqinisekiswe.
  • Ukwakha amanqatha esibindini kubantu abasela kancinci okanye bangaseli tywala (isifo sesibindi esinamafutha okanye i-NAFLD). Uninzi lophando lwakwangoko lubonisa ukuba i-resveratrol ayiphuculi ukusebenza kwesibindi, ukubola kwesibindi, okanye amanqanaba e-cholesterol kubantu abane-NAFLD.

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

  • Amabala. Uphando lwakwangoko lubonisa ukuba ukufaka ijeli ene-resveratrol ebusweni kangangeentsuku ezingama-60 kunciphisa ubungqongqo benduna.
  • Yehla kwimemori nakwizakhono zokucinga ezenzeka ngesiqhelo ngobudala. Akucaci ukuba i-resveratrol iyanceda kwimemori okanye kwizakhono zokucinga kubantu abadala. Olunye uphando lwakwangoko lubonisa ukuba i-resveratrol inokuphucula izakhono zokucinga kunye nenkumbulo kubafazi emva kokuyeka ukuya exesheni. Kodwa olunye uphando lubonisa ukuba i-resveratrol enikezwe ngeedosi eziphezulu okanye ixesha elide ayiphuculi imemori okanye izakhono zokucinga kubantu abadala abasempilweni.
  • Ukuphazamiseka kwegazi okunciphisa amanqanaba eprotini egazini elibizwa ngokuba yihemoglobin (beta-thalassemia). Uphando lwakwangoko lubonisa ukuba ukuthatha i-trans-resveratrol akuphuculi amanqanaba e-hemoglobin okanye isidingo sotofelo-gazi kubantu abane-beta-thalassemia.
  • Umhlaza. Abantu abasebenzisa izixa eziphezulu ze-resveratrol yokutya ababonakali ngathi banomngcipheko ophantsi womhlaza xa kuthelekiswa nabantu abasebenzisa izixa eziphantsi.
  • Seswekile. Olunye uphando lubonisa ukuba i-resveratrol iphucula ulawulo lweswekile egazini kubantu abanesifo seswekile. Kodwa olunye uphando alubonisi sibonelelo. I-Resveratrol inokunceda ukunciphisa iswekile yegazi kwizigulana kuphela ezinamanqanaba eswekile yegazi angalawulwa kakuhle. Uphando olungakumbi luyafuneka ukuqinisekisa.
  • Ukonakala kwezintso kubantu abanesifo seswekile (isifo seswekile). Uphando lwakwangoko lubonisa ukuba ukuthatha i-resveratrol kunye ne-losartan yeziyobisi kunokuphucula amanyathelo athile okonzakala kwezintso kubantu abane-nephropathy yeswekile.
  • Isifo semiphunga esenza ukuba kube nzima ukuphefumla (isifo esinganyangekiyo semiphunga okanye isifo seCOPD). Uphando lwakwangoko lubonisa ukuba ukuthatha imveliso edibeneyo ene-resveratrol, i-vitamin C, i-zinc, kunye ne-flavonoids kunciphisa ukukhohlela kunye nemveliso ye-mucus kubantu abane-COPD. Kodwa akucaci ukuba uncedo lubangelwa yi-resveratrol okanye ezinye izithako.
  • Osteoarthritis. Uphando lwakwangoko lubonisa ukuba ukongeza i-resveratrol kunyango oluqhelekileyo lwamadolo e-osteoarthritis kunokuphucula iintlungu, ukusebenza kunye nokuqina ngakumbi kunonyango oluqhelekileyo lodwa.
  • Ukuphucula inkqubo yonyango ebizwa ngokuba yi-peritoneal dialysis. Uphando lwakwangoko lubonisa ukuba i-resveratrol inokwenza ukucoca igazi kuhambe ngokukhawuleza kubantu abaphantsi kwe-peritoneal dialysis.
  • Ingxaki yehomoni ebangela ukwandisa ii-ovari kunye nee-cysts (i-polycystic ovary syndrome okanye i-PCOS). Uphando lwakwangoko lubonisa ukuba i-resveratrol inciphisa i-testosterone kwabasetyhini abane-PCOS. Kodwa ayibuphuculi ubunzima, amanqanaba eepidid, amabala, okanye ukukhula kweenwele okungafunekiyo kwabasetyhini abanale meko.
  • Isifo samathambo (RA). Ukuthatha i-resveratrol kunye namachiza e-RA kubonakala ngathi kunciphisa inani lamalungu abuhlungu kwaye adumbileyo. Kodwa akwaziwa ukuba i-resveratrol ikwanceda ukunciphisa umonakalo odibeneyo.
  • Uhlobo lwesifo sokukrala kwamathumbu (ulcerative colitis). Uphando lwakwangoko lubonisa ukuba i-resveratrol inokuphucula iimpawu kunye nokunciphisa umsebenzi we-ulcerative colitis.
  • Ulusu olugugileyo.
  • Ukuhla kwenkumbulo kunye nezakhono zokucinga kubantu abadala ezingaphezulu kokuqhelekileyo kubudala babo.
  • Ukuqina kwemithambo (atherosclerosis).
  • Imemori kunye nezakhono zokucinga (umsebenzi wokuqonda).
  • Ezinye iimeko.
Ubungqina obungakumbi buyafuneka ukukala i-resveratrol kwezi zinto zisetyenziswayo.

I-Resveratrol inokwandisa imithana yegazi kunye nokunciphisa umsebenzi weeseli ezibalulekileyo ekunqandeni igazi. Olunye uphando lubonisa ukuba i-resveratrol ine-estrogen ebuthathaka (ihomoni yabasetyhini). Inokunciphisa iintlungu kunye nokudumba (ukudumba). I-Resveratrol inokunciphisa amanqanaba eswekile (iswekile) egazini kwaye incede umzimba ukuba ulwe nezifo. Inokuthintela neeproteni kwingqondo ukuba zingadibani kunye ukunceda ukuthintela izifo ezifana nesifo se-Alzheimer's.

Xa kuthathwa ngomlomo: I-Resveratrol yile NGOKUKHUSELEKILEYO xa isetyenziswe kwiimali ezifumaneka kukutya. Xa uthathwa ngeedosi ukuya kuthi ga kwi-1500 mg yonke imihla ukuya kuthi ga kwiinyanga ezintathu, i-resveratrol yiyo UKHUSELEKO OLUNOKWENZEKA. Iidosi eziphezulu ukuya kuthi ga kwi-2000-3000 mg yemihla ngemihla zisetyenziswe ngokukhuselekileyo kwiinyanga ezi-2-6. Nangona kunjalo, la maqondo aphezulu e-resveratrol anokubangela iingxaki zesisu.

Xa isetyenziswa eluswini: I-Resveratrol yile UKHUSELEKO OLUNOKWENZEKA xa isetyenziswa eluswini kangangeentsuku ezingama-30.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: I-Resveratrol yile NGOKUKHUSELEKILEYO xa isetyenziswe kwimali efumaneka kukutya okuthile. Nangona kunjalo, ngexesha lokukhulelwa kunye nokuncancisa, umthombo we-resveratrol ubalulekile. I-Resveratrol ifumaneka kwizikhumba zamagilebhisi, ijusi yamagilebhisi, iwayini kunye neminye imithombo yokutya. Iwayini akufuneki isetyenziswe njengomthombo we-resveratrol ngexesha lokukhulelwa kunye nokuncancisa.

Abantwana: I-Resveratrol yile UKHUSELEKO OLUNOKWENZEKA kubantwana xa betshizwa emathatheni ukuya kwiinyanga ezi-2.

Iingxaki zokopha: I-Resveratrol inokunciphisa ukucima igazi kunye nokwandisa umngcipheko wokuphuma kwegazi kubantu abaneengxaki zokuphuma kwegazi.

Isimo esibuthathaka seHormone esifana nomhlaza webele, umhlaza wesibeleko, umhlaza we-ovari, i-endometriosis, okanye i-uterine fibroids: I-Resveratrol inokusebenza njenge-estrogen. Ukuba unayo nayiphi na imeko enokuthi yenziwe mandundu kukuvezwa kwe-estrogen, ungasebenzisi i-resveratrol.

Ugqirha: I-Resveratrol inokunyusa umngcipheko wokopha ngexesha nasemva kotyando. Yeka ukusebenzisa i-resveratrol ubuncinci kwiiveki ezi-2 ngaphambi kotyando olucwangcisiweyo.

Iphakathi
Lumka ngale nhlanganisela.
Amayeza atshintshwe sisibindi (iiCytochrome P450 1A1 (CYP1A1) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. I-Resveratrol inokunciphisa ngokukhawuleza ukuba isibindi siphula amayeza athile. Kwiingcamango, ukuthatha i-resveratrol kunye namanye amayeza aphukile ngesibindi kunokunyusa imiphumo kunye nemiphumo emibi yeminye imithi.

Amanye amayeza atshintshwe sisibindi kubandakanya i-chlorzoxazone, theophylline, kunye ne-bufuralol.
Amayeza atshintshwe sisibindi (iiCytochrome P450 1A2 (CYP1A2) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. I-Resveratrol inokunciphisa ngokukhawuleza ukuba isibindi siphula amayeza athile. Kwithiyori, ukuthatha i-resveratrol kunye namanye amayeza aphulwe sisibindi kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga zamanye amayeza.

Amanye amayeza atshintshwe sisibindi abandakanya i-clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin), propran tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), kunye nezinye.
Amayeza atshintshwe sisibindi (iiCytochrome P450 1B1 (CYP1B1) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. I-Resveratrol inokunciphisa ngokukhawuleza ukuba isibindi siphula amayeza athile. Kwiingcamango, ukuthatha i-resveratrol kunye namanye amayeza aphukile ngesibindi kunokunyusa imiphumo kunye nemiphumo emibi yeminye imithi.

Amanye amayeza atshintshwe sisibindi abandakanya i-theophylline, omeprazole, clozapine, progesterone, lansoprazole, flutamide, oxaliplatin, erlotinib, kunye ne-caffeine.
Amayeza atshintshwe sisibindi (iiCytochrome P450 2C19 (CYP2C19) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. I-Resveratrol inokunciphisa ngokukhawuleza ukuba isibindi siphula amayeza athile. Kwiingcamango, ukuthatha i-resveratrol kunye namanye amayeza aphukile ngesibindi kunokunyusa imiphumo kunye nemiphumo emibi yeminye imithi.

Amanye amayeza atshintshwe sisibindi kubandakanya amitriptyline (Elavil), carisoprodol (Soma), citalopram (Celexa), diazepam (Valium), lansoprazole (Prevacid), omeprazole (Prilosec), phenytoin (Dilantin), warfarin, kunye nabanye abaninzi.
Amayeza atshintshwe sisibindi (iiCytochrome P450 2E1 (CYP2E1) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. I-Resveratrol inokunciphisa ngokukhawuleza ukuba isibindi siphula amayeza athile. Kwithiyori, ukuthatha i-resveratrol kunye namanye amayeza aphulwe sisibindi kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga zamanye amayeza.

Amanye amayeza atshintshwe sisibindi kubandakanya i-acetaminophen, i-chlorzoxazone (iParafon Forte), i-ethanol, i-theophylline, kunye ne-anesthetics efana ne-enflurane (Ethrane), halothane (Fluothane), isoflurane (Forane), methoxyflurane (Penthrane).
Amayeza atshintshwe sisibindi (iiCytochrome P450 3A4 (CYP3A4) substrates)
Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. I-Resveratrol inokunciphisa ngokukhawuleza ukuba isibindi siphula amayeza athile. Kwithiyori, ukuthatha i-resveratrol kunye namanye amayeza aphulwe sisibindi kunokunyusa iziphumo kunye neziphumo ebezingalindelekanga zamanye amayeza. Nangona kunjalo, olunye uphando lwangaphambili lubonisa iziphumo ezingqubanayo.

Amanye amayeza atshintshwe sisibindi aquka iicalcium channel blockers (diltiazem, nicardipine, verapamil), ii-chemotherapeutic agents (etoposide, paclitaxel, vinblastine, vincristine, vindesine), ii-antifungals (ketoconazole, itraconazole), glucocorticoids, alfentanil (Alfentaide) ), fentanyl (Sublimaze), lidocaine (Xylocaine), losartan (Cozaar), fexofenadine (Allegra), midazolam (Iindidi) kunye nabanye.
Amayeza acothisa ukujiya kwegazi (iAnticoagulant / iziyobisi zeAntiplatelet)
I-Resveratrol inokunciphisa ukucima igazi. Ukuthatha i-resveratrol kunye namayeza anciphisa i-clotting kunokunyusa amathuba okugruzuka nokopha.

Amanye amayeza acothisa ukucoca igazi aquka iasprini, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, abanye), ibuprofen (Advil, Motrin, abanye), naproxen (Anaprox, Naprosyn, abanye), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), kunye nezinye.
Iherbs kunye nezongezo ezinokucothisa igazi (iAnticoagulant / Antiplatelet herbs kunye nezongezelelo)
I-Resveratrol inokunciphisa ukucima igazi. Ukuyisebenzisa kunye namanye amayeza okanye izongezo ezinokuthi zicothise ukucoca igazi kunokunyusa umngcipheko wokopha okanye ukugruzuka kwabanye abantu. Ezi zityalo zibandakanya i-angelica, i-clove, i-danshen, i-feverfew, i-garlic, i-ginger, i-ginkgo, i-ginseng i-Panax, i-chestnut yehashe, i-red clover, i-turmeric kunye nabanye
Amafutha kunye nokutya okunamafutha
Ukuthatha i-resveratrol ngesidlo esinamafutha amaninzi kunganciphisa inani le-resveratrol elifunxwe ngumzimba.
La machiza alandelayo afundwe kuphando lwezesayensi:

ABADALA

NGOMLOMO:
  • Ukunyanga kwamaxesha athile (hay fever)Izitshizi ezibini ze-0.1% ye-resveratrol yokutshiza ngeempumlo kwimpumlo nganye kathathu / ngemini ukuya kuthi ga kwiiveki ezi-4.
  • Ukutyeba kakhulu: 500 mg okanye ngaphantsi kwe-resveratrol imihla ngemihla iinyanga ezi-3 okanye ngaphezulu.
3,5,4 'TriHydroxy-Transstibene, (E) - 5- (4-hydroxystyryl) benzene-1,3-diol, 3,4', 5-stilbenetriol, 3,5,4 '-trihydroxystilbene, 3,4 ', 5-trihydroxystilbene, 3,5,4'-trihydroxy-trans-stilbene, Cis-Resveratrol, Extrait de Vin, Extrait de Vin Rouge, Kojo-Kon, Phytoalexin, Phytoalexine, Phytoestrogen, Phyto-œstrogène, Pilule de Vin Protykin, Red Wine Caphula, Resvratrat, Resveratrols, Resvratrols, RSV, RSVL, Stilbene Phytoalexin, Trans-Resveratrol, Trans-Resvratrat, Wine Caphula, Iipilisi Wine.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.


  1. UZhang N, Liang T, Jin Q, Shen C, Zhang Y, Jing P. IsiTshayina yam (iDioscorea opposita Thunb.) Kunciphisa isifo sohudo esinxulumene ne-antibiotic, kuguqula i-microbiota yamathumbu, kwaye kunyuse amanqanaba e-fatty chain fatty acids kwiimpuku. Ukutya Res Int. Ngo-2019; 122: 191-198. Jonga i-abstract.
  2. UAkbari M, Tamtaji OKANYE uLankarani KB, et al. Iziphumo zokuxhaswa kwe-resveratrol ekusebenzeni kwe-endothelial kunye noxinzelelo lwegazi phakathi kwezigulana ezine-metabolic syndrome kunye nokuphazamiseka okunxulumene noko: uphononongo olucwangcisiweyo kunye nohlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. Uxinzelelo lwegazi oluphezulu Cardiovasc Prev 2019; 26: 305-19. Jonga i-abstract.
  3. IKöbe T, iWitte AV, iSchnelle A, et al. Impembelelo ye-resveratrol kulawulo lwe-glucose, ulwakhiwo lwe-hippocampal kunye nokunxibelelana, kunye nokusebenza kwememori kwizigulana ezinokuphazamiseka kwengqondo. Ngaphambili Neurosci 2017; 11: 105. Jonga i-abstract.
  4. I-Witte AV, i-Kerti L, i-Margulies DS, i-Flöel A. Iziphumo ze-resveratrol ekusebenzeni kwememori, ukunxibelelana kokusebenza kwe-hippocampal, kunye ne-glucose metabolism kubantu abadala abasempilweni. J Neurosci 2014; 34: 7862-70. Jonga i-abstract.
  5. UMousavi SM, uMilajerdi A, uSheikhi A, et al. Ukuxhaswa kweResveratrol kunefuthe elibonakalayo kumanyathelo okutyeba kakhulu: uphononongo olucwangcisiweyo kunye novavanyo lokuphendula ngemeta yokuvavanywa kwezilingo ezilawulwa ngokungahleliwe. I-Obes Rev 2019; 20: 487-98. Jonga i-abstract.
  6. I-Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol inciphisa i-albininuria kwisifo seswekile: ilingo elilawulwa ngokungacwangciswanga elingaboniyo. Iswekile yeMetab 2019; 45: 53-9. Jonga i-abstract.
  7. UZhang C, Yuan W, Fang J, Wang W, He P, Lei J, Wang C. Ukusebenza kwesongezelelo seResveratrol ngokuchasene nezifo ezingenaSiselo esinamafutha seSibindi: Uhlalutyo lweMeta yoVavanyo lweeKlinikhi ezilawulwa yiPlacebo. Inye. Ngo-2016 uAgasti 25; 11: e0161792. Jonga i-abstract.
  8. UPoulsen MK, uNellemann B, uBibby BM, et al. Akukho siphumo se-resveratrol kwi-VLDL-TG kinetics kunye novakalelo lwe-insulin kumadoda atyebileyo anezifo zesibindi ezinamafutha. Isifo seswekile Obes Metab. 2018; 20: 2504-2509. Jonga i-abstract.
  9. I-Hussain SA, uMarouf BH, uAli ZS, uAhmmad RS. Ukusebenza kunye nokhuseleko lokulawula ngokubambisana kwe-resveratrol kunye ne-meloxicam kwizigulana ezinedolo le-osteoarthritis: uvavanyo lokungenelela kokuqhuba. Ukwaluphala kwaKlinikhi. 2018; 13: 1621-1630. Jonga i-abstract.
  10. UHuhn S, uBeyer F, uZhang R, et al. Iziphumo ze-resveratrol kwimemori yokusebenza, ukunxibelelana kwe-hippocampus kunye nolwakhiwo oluncinci kubantu abadala-Ityala elilawulwa ngokungahleliwe. Imvelaphi. Ngo-2018; 174: 177-190. Jonga i-abstract.
  11. UHaghpanah S, uZarei T, uEshghi P, et al. Ukusebenza kunye nokukhuseleka kwe-resveratrol, iarhente yomlomo ye-hemoglobin F-eyandisayo, kwizigulana ezine-beta-thalassemia intermedia. UAnn Hematol. Ngo-2018; 97: 1919-1924. Jonga i-abstract.
  12. UAnton SD, uEbner N, uDzierzewski JM, et al. Iziphumo zeentsuku ezingama-90 zokuXhaswa kweResveratrol kuMsebenzi wokuqonda kwengqondo kuBadala: Isifundo sePilot. J Enye into yokuGqibezela iMed. 2018; 24: 725-732. Jonga izishwankathelo.
  13. I-Lv C, i-Zhang Y, i-Shen L.Uvavanyo lokuqala lweklinikhi yokuvavanywa kwakhona kwe-resveratrol kubantu abadala abane-allergen rhinitis. I-Arch yeArlergy Immunol 2018; 175: 231-6. Jonga i-abstract.
  14. UZortea K, uFranco VC, uFrancesconi LP, uCereser KM, uLobato MI, uBelmonte-de-Abreu PS. Ukongezwa kweResveratrol kwiZigulana zeSchizophrenia: Uvavanyo lweKlinikhi oluLinganisiweyo oluVavanya i-Serum Glucose kunye nezinto ezinobungozi kwentliziyo. Izondlo. Ngo-2016; 8: 73. Jonga i-abstract.
  15. Wightman EL, Haskell-Ramsay CF, Reay JL, okqhubekayo. Iziphumo zokuxhaswa okungapheliyo kwe-trans-resveratrol kwimiba yokusebenza kwengqondo, imood, ukulala, impilo kunye nokuhamba kwegazi lobuchopho kubantu abasempilweni, abancinci. Br J Isondlo. Ngo-2015; 114: 1427-37. Jonga i-abstract.
  16. I-Turner RS, uThomas RG, uCraft S, et al. Uvavanyo olulawulwa ngokungahleliwe, oluyimfama, olulawulwa yi-placebo lwe-resveratrol yesifo se-Alzheimer. Neurology. Ngo-2015; 85: 1383-91. Jonga i-abstract.
  17. Ixesha lexesha S, de Ligt M, Phielix E, et al. I-Resveratrol njengonyango olongezelelekileyo kwizifundo ezinohlobo olulawulwa kakuhle lweswekile yesi-2: Isilingo esilawulwa ngokungahleliwe. Unonophelo lweSwekile. Ngo-2016; 39: 2211-2217. Jonga i-abstract.
  18. USamsami-Kor M, uDaryani NE, u-Asl PR, uHekmatdoost A.Iziphumo ezichaseneyo neResveratrol kwizigulana ezine-Ulcerative Colitis: Isifundo sePilot esilawulwa ngokungahleliwe. IArch Med Res. Ngo-2015; 46: 280-5. Jonga i-abstract.
  19. ILin CT, iLanga XY, iLin AX. Ukuxhaswa nge-high-dose trans-resveratrol yokuphucula i-ultrafiltration kwizigulane ze-peritoneal dialysis: isifundo esiza kubakho, esingahleliyo, esingaboniyo. URen uyasilela. Ngo-2016; 38: 214-21. Jonga i-abstract.
  20. IKjaer TN, i-Ornstrup MJ, iPoulsen MM, et al. I-Resveratrol inciphisa amanqanaba okujikeleza kwe-androgen ngaphambili kodwa ayinampembelelo kuyo, testosterone, dihydrotestosterone, amanqanaba e-PSA okanye ivolumu yeprostate. Ityala leenyanga ezi-4 elingenamkhethe kumadoda aphakathi. Indlala. Ngo-2015; 75: 1255-63. Jonga i-abstract.
  21. Evans HM, Howe PR, Wong RH. Iziphumo zeResveratrol kwiCognitive Performance, Mood kunye neCerebrovascular Function kwiPost-Menopausal Women; Iveki ye-14 yeTyala elilawulwa ngokuNgenelela lokuLawulwa kweNdawo. Izondlo. Ngo-2017; 9. Jonga i-abstract.
  22. I-Elgebaly A, iRadwan IA, i-AboElnas MM, et al. Ukongezwa kweResveratrol kwizigulana ezinesifo esingasinatywala esinamafutha esibindi: Ukuphononongwa kwenkqubo kunye nohlalutyo lweMeta. J Isisu sesisu seDis. Ngo-2017; 26: 59-67.Jonga i-abstract.
  23. UBo S, uPonzo V, uCiccone G, et al. Iinyanga ezintandathu zokuxhaswa kwe-resveratrol ayinasiphumo esilinganisekayo kuhlobo lwe-2 lwezigulana ezinesifo seswekile. Uvavanyo olulawulwa ngokungahleliwe, oluyimfama kabini, olulawulwa yi-placebo. IPharmacol Res. Ngo-2016; 111: 896-905. Jonga i-abstract.
  24. I-Bedada SK, Neerati P. Resveratrol Ukunyanga kwangaphambili kuchaphazela umsebenzi we-CYP2E1 we-Chlorzoxazone kumaVolontiya aBantu abaSempilweni. Phytother Res. Ngo-2016; 30: 463-8. Jonga i-abstract.
  25. Banaszewska B, Wrotynska-Barczynska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. Iziphumo zeResveratrol kwiPolycystic Ovary Syndrome: Isilingo esilawulwa kabini, esingahleliwe, esilawulwa yiPlacebo. J Ikliniki ye-Endocrinol Metab. Ngo-2016; 101: 4322-4328. Jonga i-abstract.
  26. U-Khojah HM, u-Ahmed S, u-Abdel-Rahman MS, u-Elhakeim EH. I-Resveratrol njengonyango olusebenzayo ekulawuleni i-rheumatoid arthritis: isifundo sonyango. KwiKlinikhi yaseRheumatol. 2018; [Epub phambi kokuprinta]. Jonga i-abstract.
  27. UShishodia S, uAggarwal BB. Resveratrol: ipolyphenol kuwo onke amaxesha onyaka. Resveratrol kwezempilo nakwizifo. I-Boca Raton, i-FL: ICR Press, ngo-2005.
  28. UCreasy LL, uKofu M. Phytoalexin amandla emveliso yamajikijolo omdiliya. J NdinguSoc Hortic Sci. Ngo-1988; 113: 230-234.
  29. I-Langcake P, iMcCarthy W. Ubudlelwane bemveliso ye-resveratrol yosulelo lwamagqabi omdiliya yiBotrytis cinerea. Vitis. Ngo-1979; 18: 244-253.
  30. Ixabiso NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA. I-SIRT1 iyafuneka ukuze kusebenze i-AMPK kunye neziphumo eziluncedo ze-resveratrol kwimisebenzi ye-mitochondrial. Iseli yeMetab. Ngo-2012 ngoMeyi 2; 15: 675-90. Jonga i-abstract.
  31. U-Wang S, uMoustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Inoveli yokuqonda iipolyphenols zokutya kunye nokukhuluphala. J Isondlo sebhayoloji. Ngo-2014 uJan; 25: 1-18. Jonga i-abstract.
  32. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E.Ukuthintela umkhuhlane Ukuphindaphinda intsholongwane nge-resveratrol. J Ukosulela iDis. Ngo-2005 ngoMeyi 15; 191: 1719-29. Jonga i-abstract.
  33. UMastromarino P, uCapobianco D, uCannata F, uNardis C, uMattia E, uDe Leo A, uRestignoli R, uFrancioso A, uMosca L.I-Resveratrol inqanda ukuphindaphinda kwe-rhinovirus kunye nokubonisa kwabalamli abakhoyo kwi-nasal epithelia. Intsholongwane. NgoNovemba ka-2015; 123: 15-21. Jonga i-abstract.
  34. UCrowell JA, uKorytko PJ, uMorrissey RL, uBooth TD, uLeviine BS. Inetyhefu ye-renal ehambelana ne-Resveratrol. Ityhefu yeSci. NgoDisemba wama-2004; 82: 614-9. Jonga i-abstract.
  35. I-Semba RD, i-Ferrucci L, i-Bartali B, i-Urpí-Sarda M, i-Zamora-Ros R, i-Sun K, i-Cherubini A, i-Bandinelli S, i-Andres-Lacueva C. Amanqanaba eResveratrol kwaye konke oku kubangela ukusweleka kwabantu abadala abahlala ekuhlaleni. JAMA Ngaphakathi Med. NgoJulayi 2014; 174: 1077-84. Jonga i-abstract.
  36. I-Sahebkar A.Iziphumo zokuncedisa nge-resveratrol kwiiplasma lipids: uphononongo lwenkqubo kunye nohlalutyo lweemeta zezilingo ezilawulwa ngokungahleliwe. Isityhi seNutr. 2013 Dec; 71: 822-35. Jonga i-abstract.
  37. Miraglia Del Giudice M, Maiello N, Capristo C, Alterio E, Capasso M, Perrone L, Ciprandi G.Resveratrol kunye ne-carboxymethyl-ß-glucan inciphisa iimpawu zempumlo kubantwana abane-pollen-induction allergen rhinitis. I-Curr Med Res Opin. Ngo-2014 Oktobha; 30: 1931-5. Jonga i-abstract.
  38. UMéndez-del Villar M, uGonzález-Ortiz M, uMartínez-Abundis E, uPérez-Rubio KG, uLizárraga-Valdez R. Iziphumo zolawulo lwe-resveratrol kwi-metabolic syndrome, ubuntununtunu be-insulin, kunye nokukhutshwa kwe-insulin. IMetab Syndr Relat Disord. NgoDisemba ka-2014; 12: 497-501. Jonga i-abstract.
  39. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. Cardioprotection by resveratrol: Ityala lomntu leklinikhi kwizigulana ezinesifo somthambo ozinzileyo. Iklinikhi iHemorheol Microcirc. Ngo-2012; 50: 179-87. Jonga i-abstract.
  40. U-Liu K, uZhou R, uWang B, uMi MT. Iziphumo ze-resveratrol kulawulo lwe-glucose kunye nobuntununtunu be-insulin: Uhlalutyo lweemeta lwe-11 yezilingo ezilawulwa ngokungahleliwe. NdinguJ oNyango lweeKlinikhi. NgoJuni ka-2014; 99: 1510-9. Jonga i-abstract.
  41. UFaghihzadeh F, uAdibi P, uRafiei R, uHekmatdoost A.Ukuxhaswa kweResveratrol kuphucula ii-biomarkers ezivuthayo kwizigulana ezinesifo esinamafutha esingatyisi. Indawo yokuhlala. Ngo-2014 Oktobha; 34: 837-43. Jonga i-abstract.
  42. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. I-Resveratrol ayincedi nganto kwizigulana ezinesifo esinamafutha esingatyisi isibindi. KwiKlinikhi yeGastroenterol Hepatol. NgoDisemba ka-2014; 12: 2092-103.e1-6. Jonga i-abstract.
  43. Hudson, GM, Shelmadine, B., Cooke, M., Genovese, J., Greenwood, M., kunye noWilloughby, i-DS Resveratrol Supplementation kunye notshintsho kwiGlucose, i-Insulin, kunye ne-mRNA Inkcazo yokulandela ukuzivocavoca kwabasetyhini abangaphezulu komzimba: 2467. Inzululwazi kwezemidlalo kunye nokuzivocavoca ngo-2011; 43
  44. UGuarnieri, R., uPappacoda, A., kunye noSolitro, S. [I-resveratrol equlathe ikhompawundi inciphisa uxinzelelo lwe-oxidative kwaye iyalungisa iimpawu zeklinikhi kwizifundo zeCOPD] Un composto is a di diververatrolo riduce lo stress ossidativo e migliora la sintomatologia clinica in soggetti con BPCO . ICochrane Central Register yeeTyala eziLawulwa ngo-2009;
  45. Yoon, SJ, Cho, KS, Lee, YH, Kim, DS, no-Hong, SJ RESVERATROL INHIBITS CXCR4 MEDIATED TUMOR GROWTH AND FIGRATION OF HUMAN BIDNEY CERER CELL KWI-VITRO NAKU-VIVO: 428. Ijenali ye-Urology 2009; 181: 153- 154.
  46. Klink, JC, Poulton, S., Antonelli, J., Potter, MQ, Jayachandran, J., Tewari, AK, Febbo, PG, Pizzo, SV, naseFreedland, S. RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT UKUKHULA: 724. Ijenali yeUrology 2009; 181
  47. Ngokufanelekileyo, K. A. I-Cannabinoid receptor inverse agonists njenge-arhente yonyango yenoveli. "IiNzululwazi nobuNjineli. IiNzululwazi kunye nezoBunjineli 2009; 70 (4-B)
  48. Pregliasco, F. and Cogo, R. [Antioxidant and immunomodulating compounds kubantu abadala abaphantsi kogonyo lwexesha lomkhuhlane baphucula impendulo ye-serological kunye nokunciphisa iziqendu zokuphefumla] L'uso di sostanze antiossidanti ed immunomodulanti in una popolazione anziana so. ICochrane Central Register yeZilingo eziLawulwayo ngo-2010;
  49. USteigerwald, M. D., Fisk, M. Z., Smoliga, J. M., kunye noRundell, K. W. Iziphumo zeResveratrol kuXinzelelo lwe-Oxidative kunye nokuSebenza kweVascular Emva kokuzilolonga kuLungiso lomoya olulinganisiweyo: 2645. Amayeza kunye neNzululwazi kwiMidlalo noQeqesho 2011; 43
  50. I-Bost, J., Smoliga, JM, Bost, KM, kunye neMaroon, i-JC iinyanga ezintathu zokuNcediswa komlomo kweNdawo eyahlukileyo yePolyphenol Iphucula iZalathi zeNtsebenzo kunye neNeurocognitive kwi-Sedentary Adult: 2205. Amayeza kunye neNzululwazi kwiMidlalo kunye noQeqesho 2008; 40: S246 .
  51. UGrujic Milanovic, J., Mihailovic-Stanojevic, N., Miloradovic, Z., Jacevic, V., Milosavljevic, I., Milanovic, S., Ivanov, M., noJovovic, U-DJ RESVERATROL UNCIPHISA UXINEZELELO LWEGAZI, UTSHINTSHO LWE-ANTIOXIDANT UMSEBENZI WENDAWO YENKQUBO KUNYE NEZIMBALI ZEMBALI KWIModeli YOKUQHELEKA KWE-MALIGNANT HYPERTENSION PP.29.171. Ijenali yoxinzelelo lwegazi 2010; 28
  52. I-Pendurthi, U. R., Williams, J. T., kunye ne Rao, L. V. Resveratrol, indawo ene polyphenolic efumaneka ewayinini, inqanda ukubonakaliswa kwethishu kwiiseli zemithambo: Indlela enokubakho yesibonelelo sentliziyo esinxulunyaniswa nokusetyenziswa ngokuphakathi kwewayini. IArterioscler iTromb. IVasc. IBiol 1999; 19: 419-426. Jonga i-abstract.
  53. IRotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., kunye noCerletti, C. Iziphumo ze-trans-resveratrol, i-polyphenolic yendalo. ikhompawundi, ekusebenzeni kweepolymorphonuclear leukocyte. UBr. J. Pharmacol. (PubMed) (Umnqamlezo) Ngo-1998; 123: 1691-1699. Jonga i-abstract.
  54. Bhatt, J. K., Thomas, S., kunye noNanjan, M. J. Resveratrol supplementation kuphucula ukulawulwa kwe-glycemic kuhlobo lwe-2 yeswekile. Isondlo Res. Ngo-2012; 32: 537-541. Jonga i-abstract.
  55. Hector, K. L., Lagisz, M., kunye noNakagawa, S. Iziphumo ze-resveratrol kubomi obude kwiindidi zonke: uhlalutyo lweemeta. Utywala. 10-23-2012; 8: 790-793. Jonga i-abstract.
  56. Roehr, B. Umphandi wentliziyo wenza idatha kwizifundo zewayini ebomvu. BMJ 2012; 344: e406. Jonga i-abstract.
  57. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., kunye no-Barzilai, N. Pilot yokufunda nge-resveratrol kubantu abadala abanengxaki yokunganyamezeli iswekile. J. Gerontol, Biol. Inzululwazi, iMed.Sci. Ngo-2012; 67: 1307-1312. Jonga i-abstract.
  58. Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., kunye neDas, DK Ukulungiswa kwe-resveratrol iLongevinex iphucula ukusebenza kwe-endothelial kubantu abadala abane-syndrome ye-metabolic abafumana unyango oluqhelekileyo. Izondlo 2011; 31: 842-847. Jonga i-abstract.
  59. Ixesha, S., uKonings, E., Bilet, L., Houtkooper, RH, van de Weijer, T., Goossens, GH, Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S ., Moonen-Kornips, E., Hesselink, MK, Kunz, I., Schrauwen-Hinderling, VB, Blaak, EE, Auwerx, J., and Schrauwen, P. Calorie-like-effects of 30 days of resveratrol supplementation on. imetabolism yamandla kunye neprofayili ye-metabolic kubantu abatyebe kakhulu. Iseli yeMetab 11-2-2011; 14: 612-622. Jonga i-abstract.
  60. UXuzhu, G., Komai-Koma, M., Leung, B. P., Howe, H. S., McSharry, C., McInnes, I. B., kunye no-Xu, D. I-Resveratrol imodareyitha i-murine collagen-indened arthritis ngokuthintela ukusebenza kwe-Th17 kunye ne-B-cell. UAnn.Rheum. Dis 2012; 71: 129-135. Jonga i-abstract.
  61. Knight, CM, Gutierrez-Juarez, R., Lam, TK, Arrieta-Cruz, I., Huang, L., Schwartz, G., Barzilai, N., kunye noRossetti, L. Mediobasal hypothalamic SIRT1 ibalulekile kwiziphumo ze-resveratrol. kwisenzo se-insulin kwiigundane. Iswekile 2011; 60: 2691-2700. Jonga i-abstract.
  62. Howell, LM, Berry, DP, Elliott, PJ, Jacobson, EW, Hoffmann, E., Hegarty, B., Brown, K., Steward, WP, kunye noGescher, Isigaba se-AJ, I-randomized, i-pilot-blind blind study of micronized i-resveratrol (i-SRT501) kwizigulana ezine-hepatic metastases-ukhuseleko, i-pharmacokinetics, kunye ne-pharmacodynamics. Umhlaza ngaphambili. Res (Phila) 2011; 4: 1419-1425. Jonga i-abstract.
  63. Wuertz, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, A., Konno, S., Kikuchi, S., kunye neBoos, N. Iwayini ebomvu i-polyphenol resveratrol ibonisa amandla anokubakho Unyango lwe-nucleus pulposus-Mediated pain in vitro nakwi-vivo. Umqolo (Phila Pa 1976.) 10-1-2011; 36: E1373-E1384. Jonga i-abstract.
  64. Brasnyo, P., Molnar, GA, Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, IA, Merei, A., Halmai, R., Meszaros, I-LG, Sumegi, B., kunye neWittmann, I. I-Resveratrol iphucula ubuntununtunu be-insulin, inciphisa uxinzelelo lwe-oxidative kwaye isebenze indlela ye-Akt kuhlobo lwe-2 lwezigulana zeswekile. Br J Isondlo. Ngo-2011; 106: 383-389. Jonga i-abstract.
  65. UFabbrocini, G., Staibano, S., De, Rosa G., Battimiello, V., Fardella, N., Ilardi, G., La Rotonda, MI, Longobardi, A., Mazzella, M., Siano, M. , Pastore, F., De, Vita, V, Vecchione, ML, kunye no-Ayala, F.I-Resveratrol ene-gel yokunyanga i-acne vulgaris: i-blind-blind, elawulwa yimoto, isifundo somqhubi. NdinguJ. Clin. EDermatol 4-1-2011; 12: 133-141. Jonga i-abstract.
  66. I-Kitada, M., Kume, S., Imaizumi, N., kunye ne-Koya, D.I-Resveratrol iphucula uxinzelelo lwe-oxidative kwaye ikhusela isifo se-nephropathy yeswekile ngokwesiqhelo ukungasebenzi kakuhle kwe-Mn-SOD kwi-AMPK / SIRT1-indlela ezimeleyo. Iswekile 2011; 60: 634-643. Jonga i-abstract.
  67. UShindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D., noRostami, A. I-resveratrol yomlomo inciphisa umonakalo we-neuronal kwimodeli ye-multiple sclerosis. J Neuroophthalmol. Ngo-2010; 30: 328-339. Jonga i-abstract.
  68. UBrown, VA, Patel, KR, Viskaduraki, M., Crowell, JA, Perloff, M., Booth, TD, Vasilinin, G., Sen, A., Schinas, AM, uPiccirilli, G., uBrown, uK. Steward, WP, Gescher, AJ, kunye no-Brenner, DE Ukuphindaphinda isifundo sethamo somhlaza sokukhusela iarhente yamavolontiya asempilweni: ukhuseleko, i-pharmacokinetics, kunye nefuthe kwi-axis efana nokukhula kwezinto. Umhlaza Res 11-15-2010; 70: 9003-9011. Jonga i-abstract.
  69. Patel, KR, Brown, VA, Jones, DJ, Britton, RG, Hemingway, D., Miller, AS, West, KP, Booth, TD, Perloff, M., Crowell, JA, Brenner, DE, Steward, WP, UGescher, AJ, kunye noBrown, K. Clinical pharmacology ye-resveratrol kunye nemetabolites yayo kwizigulana ezinomhlaza. Umhlaza Res 10-1-2010; 70: 7392-7399. Jonga i-abstract.
  70. Knobloch, J., Sibbing, B., Jungck, D., Lin, Y., Urban, K., Stoelben, E., Strauch, J., kunye noKoch, A. I-Resveratrol yonakalisa ukukhutshwa kwee-cytokines ezinganyangekiyo ze-steroid. ukusuka kwiiseli zemisipha egudileyo yomoya kwisifo esinganyangekiyo semiphunga. J Pharmacol Ingcaciso ka-2010; 335: 788-798. Jonga i-abstract.
  71. I-Chow, HH, Garland, LL, Hsu, CH, Vining, DR, Chew, WM, Miller, JA, Perloff, M., Crowell, JA, kunye neAlberts, i-DS Resveratrol imodareyitha iziyobisi kunye ne-carcinogen-metabolizing enzymes kwivolontiya elisempilweni. ukufunda. Umhlaza ngaphambili. Res (Phila) 2010; 3: 1168-1175. Jonga i-abstract.
  72. Wong, R.H, Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., kunye no-Berry, N. M. Acute resveratrol supplementation kuphucula ukuhamba-phakathi kokutyeba / ukutyeba kwabantu abonyuse uxinzelelo lwegazi. Isondlo Metab Cardiovasc. Dis 2011; 21: 851-856. Jonga i-abstract.
  73. la, Porte C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., kunye noCameron, DW Steady-State pharmacokinetics kunye nokunyamezeleka kwe-trans-resveratrol 2000 mg kabini imihla ngemihla ukutya, i-quercetin kunye notywala (i-ethanol) kwizifundo ezinempilo zabantu. Iklinikhi yePharmacokinet. Ngo-2010; 49: 449-454. Jonga i-abstract.
  74. U-Le Couteur, u-D.G kunye no-Sinclair, u-D.A uyilo lokuphuhlisa iindlela zonyango ezonyusa indawo yezempilo kunye nokulibazisa ukufa. J Gerontol. Biol. Inzululwazi yezoLwazi. Ngo-2010; 65: 693-694. Jonga i-abstract.
  75. UKennedy, DO, Wightman, EL, Reay, JL, Lietz, G., Okello, EJ, Wilde, A., noHaskell, Iziphumo zeCF ze-resveratrol kwii-cerebral flow flow variables kunye nokusebenza kwengqondo ebantwini: blind-blind, placebo -ukulawulwa, uphando lwe-crossover. NdinguJ Kliniki. Ngo-2010; 91: 1590-1597. Jonga i-abstract.
  76. UDaffner, K. R. Ukukhuthaza ukwaluphala kwengqondo okuphumeleleyo: uphononongo olubanzi. J iAlzheimers. Dis 2010; 19: 1101-1122. Jonga i-abstract.
  77. Yu, H. P., Hwang, T. L., Hwang, T. L., Yen, C.H, kunye noLau, Y.T.Resveratrol kuthintela ukungasebenzi kakuhle kwe-endothelial kunye nokuveliswa kwe-aortic superoxide emva kwengozi yokuqaqanjelwa sisisu ngokusebenzisa i-estrogen receptor-hemeoxygenase-1 indlela. Unonophelo lweCrit Med 2010; 38: 1147-1154. Jonga i-abstract.
  78. U-Albani, D., Polito, L., no-Forloni, G. Sirtuins njengeethagethi ezijolise kwisifo se-Alzheimer kunye nezinye iingxaki ze-neurodeergenerative: ubungqina bovavanyo nolofuzo. J IAlzheimers. Dis 2010; 19: 11-26. Jonga i-abstract.
  79. Guo, J. P., Yu, S., kunye noMcGeer, P. L. Iilingo ezilula ze-vitro zokuchonga i-amyloid-beta aggregation blockers yonyango lwesifo se-Alzheimer. J iAzheimer. Dis. Ngo-2010; 19: 1359-1370. Jonga i-abstract.
  80. UJha, R. K., Ma, Q., Sha, H., kunye noPalikhe, M. Isiphumo sokukhusela i-resveratrol kwingozi yokulimala kwengqondo ebukekayo. Iipancreas 2009; 38: 947-953. Jonga i-abstract.
  81. UZhang, H., Zhang, J., Ungvari, Z., kunye noZhang, C.I-Resveratrol iphucula ukusebenza kwe-endothelial: indima ye-TNF {alpha} kunye noxinzelelo lwe-vascular oxidative. IArterioscler iTromb.Vasc.Ibhayol. Ngo-2009; 29: 1164-1171. Jonga i-abstract.
  82. I-Bournival, J., Quessy, P., kunye noMartinoli, M. G. Iziphumo zokukhusela i-resveratrol kunye ne-quercetin ngokuchasene ne-MPP + -ukunyanzeliswa kwesenzo soxinzelelo lwe-oxidative ngokumodareyitha kweempawu zokufa kwe-apoptotic kwii-dopaminergic neurons. Iseli Mol. Ngo-2009; 29: 1169-1180. Jonga i-abstract.
  83. UAlmeida, uL., Vaz-da-Silva, M., Falcao, A., Soares, E., Costa, R., Loureiro, AI, Fernandes-Lopes, C., Rocha, JF, Nunes, T., Wright. , L., kunye ne-Soares-da-Silva, P. Pharmacokinetic kunye nokhuseleko kwiprofayili ye-trans-resveratrol kwisifundo esikhulayo sedosi kumavolontiya asempilweni. Ukutya Res Mol 2009; 53 Suppl 1: S7-15. Jonga i-abstract.
  84. UVingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., kunye noMambaud, P. Unyango olunokubakho lokuphinda kubekhona isifo kwi-Alzheimer's's disease. I-BMC yeNeurosci. Ngo-2008; 9 iSuppl 2: S6. Jonga i-abstract.
  85. UFan, E., Zhang, L., Jiang, S., kunye noBai, Y. Iziphumo eziluncedo ze-resveratrol kwi-atherosclerosis. J Med Ukutya ngo-2008; 11: 610-614. Jonga i-abstract.
  86. IVaz-da-Silva, M., Loureiro, AI, Falcao, A., Nunes, T., Rocha, JF, Fernandes-Lopes, C., Soares, E., Wright, L., Almeida, L., kunye I-Soares-da-Silva, P. Iziphumo zokutya kwiprofayile ye-pharmacokinetic ye-trans-resveratrol. Int. J Clin. Pharmacol. 2008; 46: 564-570 (PubMed) (Umnqamlezo) Jonga i-abstract.
  87. UDudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A., kunye noDas, D. K. Ngaba iwayini emhlophe iyakulungela ukuphikisana neFrance? Thelekisa iimpembelelo zentliziyo ezibomvu nezimhlophe zewayini kunye nezinto zabo: i-resveratrol, i-tyrosol, kunye ne-hydroxytyrosol. J Agric. Ukutya Chem. 10-22-2008; 56: 9362-9373. Jonga i-abstract.
  88. U-Orallo, F. Trans-resveratrol: isiyobisi somlingo sobutsha banaphakade? I-Curr, uMed Chem. Ngo-2008; 15: 1887-1898. Jonga i-abstract.
  89. URocha-Gonzalez, H. I., Ambriz-Tututi, M., kunye neGranados-Soto, V.I-Resveratrol: indalo yendalo enokubakho kwi-pharmacological kwizifo ze-neurodeergenerative. Ngomhla we-2008; 14: 234-247. Jonga i-abstract.
  90. ICalabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, TE, Giuffrida Stella, AM, Schapira, T., Dinkova Kostova, AT, kunye URizzarelli, E. Impendulo yoxinzelelo lweselula: inqaku ekujolise kulo kuthintelo lwe-chemoprevention kunye ne-neuroprotection yesondlo ekwaluphaleni, ukuphazamiseka kwemithambo-luvo kunye nokuphila ixesha elide. Neurochem. Res 2008; 33: 2444-2471 (PubMed) (Umnqamlezo) Jonga i-abstract.
  91. I-Pearson, KJ, Baur, JA, Lewis, KN, Peshkin, L., Ixabiso, NL, Labinskyy, N., Swindell, WR, Kamara, D., Omncinci, RK, Perez, E., Jamieson, HA, Zhang, Y., Dunn, SR, Sharma, K., Pleshko, N., Woollett, LA, Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, PJ, Becker, KG, Navas, P., Ingram, DK, Wolf, NS, Ungvari, Z., Sinclair, DA, kunye de Cabo, R.Resveratrol ukulibaziseka ukonakala okunxulumene nobudala kunye nokulinganisa izinto ezikhutshelweyo zokuthintela ukutya ngaphandle kokunabisa ubomi. Iseli yeMetab 2008; 8: 157-168. Jonga i-abstract.
  92. UDong, W., Li, N., Gao, D., Zhen, H., Zhang, X., kunye no-Li, F.I-Resveratrol inciphisa umonakalo we-ischemic engqondweni kwisigaba sokulibaziseka emva kokubetha kwaye yenza ukuba i-RNA yomthunywa kunye neprotheni iveze i-angiogenic izinto. J Vasc Uvavanyo. Ngo-2008; 48: 709-714. Jonga i-abstract.
  93. Yu, H. P., Hsu, J. C., Hwang, T. L., Yen, C.H, kunye noLau, Y.T.I-Resveratrol iyanciphisa ukulimala kwe-hepatic emva kwengozi-yokuphuma kwegazi ngokusebenzisa indlela ehambelana ne-estrogen. Umothuko 2008; 30: 324-328. Jonga i-abstract.
  94. IBass, T. M., Weinkove, D., Houthoofd, K., Gems, D., kunye nePartridge, L. Iziphumo ze-resveratrol kubomi be-Drosophila melanogaster kunye ne-Caenorhabditis elegans. Mech Ukwaluphala kwi-Dev 2007; 128: 546-552. Jonga i-abstract.
  95. Gruber, J., Tang, S. Y., kunye noHalliwell, B.Ubungqina bokurhweba phakathi kokusinda kunye nokuqina komzimba okubangelwa lunyango lwe-resveratrol ye-Caenorhabditis elegans. UAnn N Y. Acad Sci 2007; 1100: 530-542. Jonga i-abstract.
  96. UBaur, uJ. A. kunye noSinclair, D. A. Unyango olunokubakho lwe-resveratrol: ubungqina be-vivo. Nat Rev iziyobisi Discov. Ngo-2006; 5: 493-506. Jonga i-abstract.
  97. UValenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., noCellerino, A. Resveratrol yongeza ixesha lokuphila kwaye ibuyisa ukuqala kokumakisha okunxulumene nobudala kwitebhrithi efutshane. ICurr Biol 2-7-2006; 16: 296-300. Jonga i-abstract.
  98. URakici, O., Kiziltepe, U., Coskun, B., Aslamaci, S., kunye no-Akar, F. Iziphumo ze-resveratrol kwithoni ye-vascular kunye nokusebenza kwe-endothelial ye-vein saphenous vein kunye ne-mammary artery yangaphakathi. Int. J Cardiol 11-2-2005; 105: 209-215 (PubMed) (Umnqamlezo) Jonga i-abstract.
  99. Ma, Z.H kunye noMa, Q.Y.Resveratrol: iyeza lonyango lwe-pancreatitis ebukhali. Kwihlabathi J Gastroenterol. 6-7-2005; 11: 3171-3174. Jonga i-abstract.
  100. UMolnar, V. kunye noGarai, J. Izityalo ezivela kwizityalo ezichasene nokuvuvukala zichaphazela umsebenzi we-MIF tautomerase. Int. Ngo-2005; 5: 849-856. Jonga i-abstract.
  101. I-Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Di Stasio, G., kunye neSmorlesi, A. Iziphumo ze-resveratrol kuphuhliso lwezidumbu ezizenzekelayo kwi-HER-2 / Iimpuku ze-transgenic. Int. J Umhlaza 5-20-2005; 115: 36-45. Jonga i-abstract.
  102. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., kunye no-Takada, Y. Indima ye-resveratrol kuthintelo kunye nonyango lomhlaza: izifundo zangaphambi konyango kunye nonyango. I-Anticancer Res. Ngo-2004; 24 (5A): 2783-2840. Jonga i-abstract.
  103. UWalle, T., Hsieh, F., DeLegge, M.H, Oatis, J. E., Jr., noWalle, U. K. Ukufunxwa okuphezulu kodwa ukufumaneka okuphantsi kakhulu kwe-resveratrol yomlomo ebantwini. Ukuchithwa kweMetab yeziyobisi. Ngo-2004; 32: 1377-1382. Jonga i-abstract.
  104. UJannin, B., Menzel, M., Berlot, J. P., Delmas, D., Lancon, A., noLatruffe, N. Ukuthuthwa kwe-resveratrol, i-arhente ye-chemopreventive arhente, kwiithagethi zeselfowuni: iplasmatic protein yokubopha kunye nokuthathwa kweseli. Utshintsho kwiPharmacol. 9-15-2004; 68: 1113-1118. Jonga i-abstract.
  105. Evers, D. L., Wang, X., Huong, S. M., Huang, D. Y., kunye noHuang, E. S. 3,4 ', 5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cell signaling. Intsholongwane. Ngo-2004; 63: 85-95. Jonga i-abstract.
  106. Piver, B., Fer, M., Vitrac, X., Merillon, JM, Dreano, Y., Berthou, F., kunye noLucas, D. Ukubandakanywa kwe-cytochrome P450 1A2 kwi-biotransformation ye-trans-resveratrol kwii-microsomes zesibindi somntu. . Utshintsho kwiPharmacol. 8-15-2004; 68: 773-782. Jonga i-abstract.
  107. Umthi, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., kunye noSinclair, D. Abavuseleli beSirtuin balingisa isithintelo sekhalori kunye nokulibazisa ukuguga kwimetazoans. Ubume 8-5-2004; 430: 686-689. Jonga i-abstract.
  108. U-Olas, B., Wachowicz, B., Bald, E., noGlowacki, R. Iziphumo zokukhusela i-resveratrol ngokuchasene notshintsho lweeplatelet zegazi ezibangelwa ziiplatinam. UJ. Physiol Pharmacol. Ngo-2004; 55: 467-476. Jonga i-abstract.
  109. ICavallaro, A., Ainis, T., Bottari, C., kunye noFimiani, V. Iziphumo zokuphinda ubuyekeze kwakhona kwimisebenzi ethile yodwa kunye negazi elipheleleyo lomntu neutrophils. IPhysol Res. Ngo-2003; 52: 555-562. Jonga i-abstract.
  110. I-Kim, YA, Lee, WH, Choi, TH, Rhee, SH, Park, KY, kunye neChoi, YH Ukubandakanywa kwe-p21WAF1 / CIP1, pRB, Bax kunye ne-NF-kappaB ekwandiseni ukubanjwa kokukhula kunye ne-apoptosis yi-resveratrol kwi-lung lung carcinoma Iiseli ezingama-A549. Int. J. Onol. Ngo-2003; 23: 1143-1149. Jonga i-abstract.
  111. Howitz, KT, Bitterman, KJ, Cohen, HY, Lamming, DW, Lavu, S., Wood, JG, Zipkin, RE, Chung, P., Kisielewski, A., Zhang, LL, Scherer, B., kunye noSinclair. , I-DA encinci yeemolekyuli ezisebenzayo ze-sirtuins zandisa i-Saccharomyces cerevisiae ubomi. Indalo 9-11-2003; 425: 191-196. Jonga i-abstract.
  112. UDelmas, D., uRebe, uC., ULacour, uS., UFilomenko, uR, uAthias, uA, uGambert, uP., UCherkaoui-Malki, uM, uJannin, uB, uDubrez-Daloz, uL, uLatruffe. , N., kunye neSolary, E.I-apoptosis ebangelwa yi-Resveratrol inxulunyaniswa nokusasazwa kwakhona kwe-Fas kwizihlenga kunye nokwenziwa kokubonisa ukubulala okubonisa ukuntsokotha kweeseli zomhlaza wekolon. UJiol. Chem. 10-17-2003; 278: 41482-41490. Jonga i-abstract.
  113. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., kunye no-Lin, J. K. Resveratrol-eyenzelwe ukubanjwa kwe-G2 ngokuthintela i-CDK7 kunye ne-p34CDC2 kinases kwi-colon carcinoma iiseli ze-HT29. Utshintsho kwiPharmacol. 4-1-2003; 65: 1053-1060. Jonga i-abstract.
  114. UKlinge, C. M., Risinger, K. E., Watts, M. B., Beck, V., Eder, R., noJungbauer, A. Umsebenzi we-Estrogenic kwimigca yewayini emhlophe nebomvu. J Agric. Ukutya Chem 3-26-2003; 51: 1850-1857. Jonga i-abstract.
  115. IVitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., kunye neMerillon, JM Distribution ye [14C] -itrans-resveratrol, a umhlaza chemopreventive polyphenol, kwizihlunu zegundane emva kolawulo lomlomo. Ubomi beSayensi 4-4-2003; 72: 2219-2233. Jonga i-abstract.
  116. I-Levenson, AS, Gehm, BD, Pearce, ST, Horiguchi, J., Simons, LA, Ward, JE, III, Jameson, JL, kunye neJordani, i-VC Resveratrol isebenza njenge-agonist ye-estrogen receptor (ER) kwiiseli zomhlaza wamabele ngokuzinzileyo. Idluliselwe nge-alpha ye-ER. Int. J. Umhlaza 5-1-2003; 104: 587-596. Jonga i-abstract.
  117. U-Yu, C., Shin, Y. Ukukhawuleza Commun. Mass Spectrom. Ngo-2003; 17: 307-313. Jonga i-abstract.
  118. Olas, B., Wachowicz, B., Saluk-Juszczak, J., kunye no-Zielinski, T. Iziphumo ze-resveratrol, indalo ye-polyphenolic, kwi-platelet activation eyenziwe yi-endotoxin okanye i-thrombin. Itromb. IRes 8-15-2002; 107 (3-4): 141-145. Jonga i-abstract.
  119. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., kunye noForstermann, U. Resveratrol, i-polyphenolic phytoalexin ekhoyo kwiwayini ebomvu, yongeza intetho kunye nomsebenzi endothelial nitric oxide synthase. Ukuhamba kwe-9-24-2002; 106: 1652-1658. Jonga i-abstract.
  120. USharma, M. kunye noGupta, uYK K. Unyango olunganyangekiyo nge-trans resveratrol kuthintela i-intracerebroventricular streptozotocin ebangela ukukhubazeka kwengqondo kunye noxinzelelo lwe-oxidative kwiigundane. Ubomi beSayensi 10-11-2002; 71: 2489-2498. Jonga i-abstract.
  121. UHolian, O., Wahid, S., Atten, M. J., kunye no-Attar, B. M. Ukuthintela ukwanda kwesifo somhlaza esiswini nge-resveratrol: indima ye-nitric oxide. NdinguJ. Physiol Gastrointest. Isibindi sePhysiol 2002; 282: G809-G816. Jonga i-abstract.
  122. Umbumbi, GA, Patterson, LH, Wanogho, E., Perry, PJ, Butler, PC, Ijaz, T., Ruparelia, KC, Lamb, JH, Farmer, PB, Stanley, LA, kunye noBurke, MD I-resveratrol iguqulwa yaya kwi-arhente ye-anticancer piceatannol yi-cytochrome P450 enzyme CYP1B1. Br. J. Umhlaza 3-4-2002; 86: 774-778. Jonga i-abstract.
  123. UFalchetti, R., Fuggetta, M. P., Lanzilli, G., Tricarico, M., kunye noRavagnan, G. Iziphumo ze-resveratrol ekusebenzeni kweseli yomzimba womntu. Inzululwazi yoBomi. 11-21-2001; 70: 81-96. Jonga i-abstract.
  124. Bhavnani, BR, Cecutti, A., Gerulath, A., Woolever, AC, kunye noBerco, M. Thelekisa iimpembelelo ze-antioxidant ze-equine estrogens, izinto ezibomvu zewayini, i-vitamin E, kunye ne-probucol kwi-low-density lipoprotein oxidation kubafazi be-postmenopausal . Ukuyeka ukuya exesheni. 2001; 8: 408-419. Jonga i-abstract.
  125. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C., kunye noPezzuto, J. M. Estrogenic kunye ne-antiestrogenic iipropathi ze-resveratrol kwiimodeli zamathumba. Umhlaza Res. I-10-15-2001; 61: 7456-7463. Jonga i-abstract.
  126. U-Lee, uJ. E. noKhuselekileyo, S. Ukubandakanywa kwendlela yokukhutshelwa emva kokubhalwa kwe-CYP1A1 expression by resveratrol in cell cancer cells. Utshintsho kwiPharmacol. 10-15-2001; 62: 1113-1124. Jonga i-abstract.
  127. I-Bhat, K. P. kunye ne-Pezzuto, J. M. Resveratrol ibonisa iipropathi ze-cytostatic kunye ne-antiestrogenic ezineeseli ze-endometrium adenocarcinoma (Ishikawa). Umhlaza Res. 8-15-2001; 61: 6137-6144. Jonga i-abstract.
  128. UNicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A., kunye noTredici, G. Isiphumo sokulwa ne-apoptotic ye-trans-resveratrol kwi-paclitaxel-indased apoptosis kwi-neuroblastoma yomntu SH-SY5Y umgca weseli. I-Neurosci. 4-13-2001; 302: 41-44. Jonga i-abstract.
  129. UGiovannini, L., Migliori, M., Longoni, BM, Das, DK, Bertelli, AA, Panichi, V., Filippi, C., noBertelli, A. Resveratrol, ipolyphenol efumaneka ewayinini, inciphisa ischemia ukuphinda yenzeke izintso zempuku. J Cardiovasc, iParmacol. 2001; 37: 262-270. Jonga i-abstract.
  130. UChan, W. K. noDelucchi, A. B. I-Resveratrol, indawo ebomvu yewayini, yindlela esekwe kwi-cytochrome P450 3A4. Ubomi beSayensi 11-10-2000; 67: 3103-3112. Jonga i-abstract.
  131. UWang, M. J., Huang, H. M., Hsieh, S. J., Jeng, K. C., noKuo, J. S. Resveratrol inqanda imveliso ye-interleukin-6 kwiiseli ezixubeneyo ze-glial cell phantsi kwehypoxia / hypoglycemia elandelwa kukuphinda kwenziwe amandla kwakhona. J Neuroimmunol. 1-1-2001; 112 (1-2): 28-34. Jonga i-abstract.
  132. U-Chang, u-T., U-Lee, u-B, no-Ko, u-H.H.Trans-resveratrol uyimodareyitha imisebenzi ye-catalytic kunye ne-mRNA expression yeprocarcinogen-activating cytochrome yabantu P450 1B1. Ngaba. J. Physiol Pharmacol. Ngo-2000; 78: 874-881. Jonga i-abstract.
  133. Burkitt, M.J kunye noDuncan, J. Iziphumo ze-trans-resveratrol kuyilo oluxhomekeke kubhedu lwe-hydroxyl-radical ukwakheka kunye nomonakalo we-DNA: ubungqina bokuba i-hydroxyl-radical scavenging kunye nenoveli, indlela yokusindisa ye-glutathione. IArch. Ibhayoloji. 9-15-2000; 381: 253-263. Jonga i-abstract.
  134. UZbikowska, H. M. kunye no-Olas, B.Iiantioxidants ezinomsebenzi we-carcinostatic (i-resveratrol, i-vitamin E kunye ne-selenium) ekumodareyithweni kweplatelet yegazi. J iPhysiol Pharmacol. Ngo-2000; 51: 513-520. Jonga i-abstract.
  135. Kirk, R. I., Deitch, J. A., Wu, J. M., kunye noLerea, K. M. Resveratrol inciphisa iziganeko zokuqala zokutyikitya kwiiplatelet ezigeziweyo kodwa zinefuthe elincinci kwiplatlet ekutyeni konke. Iiseli zegazi Mol. Dis. Ngo-2000; 26: 144-150. Jonga i-abstract.
  136. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S. S., kunye noPruess, H. G. Radicals simahla kunye nembewu yediliya iproanthocyanidin isicatshulwa: ukubaluleka kwimpilo yabantu kunye nokuthintela izifo. Ityhefu 8-7-2000; 148 (2-3): 187-197. Jonga i-abstract.
  137. UBradamante, S., Piccinini, F., Barenghi, L., Bertelli, A. A., De Jonge, R., Beemster, P., kunye noDe Jong, J. W. Ngaba ukuphinda ubuyisele kwisilonda kubangela ukubekwa kwangaphambili kwemichiza? Int. J yeeTissue React. Ngo-2000; 22: 1-4. Jonga i-abstract.
  138. UNaderali, E.K, Doyle, P.J, kunye noWilliams, G.Resveratrol inducate vasorelaxation ye-mesenteric kunye ne-uterine artery evela kwi-guinea-pigs yabasetyhini. Iiklinikhi yeSci (uLond) 2000; 98: 537-543. Jonga i-abstract.
  139. IKlabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., kunye neSacchettini, J. C. Uyilo oluhle loyilo lomntu onamandla we-transthyretin amyloid isifo inhibitors. Ulwakhiwo lukaNat. Ngo-2000; 7: 312-321. Jonga i-abstract.
  140. UMartinez, uJ. Kunye noMoreno, uJ. J. Iziphumo ze-resveratrol, indalo ye-polyphenolic, kwiindidi zeoksijini ezisebenzayo kunye nemveliso yeprostaglandin. I-Biochem. IPharmacol 4-1-2000; 59: 865-870. Jonga i-abstract.
  141. I-Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., Telang, N., kunye noDannenberg, A. J. Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cell. Ann NN.Acad.Sci. Ngo-1999; 889: 214-223. Jonga i-abstract.
  142. UDobrydneva, Y., Williams, R. L., kunye noBlackmore, P. F. trans-Resveratrol inqanda ukungena kwecalcium kwiiplatelets zabantu ezikhuthazayo. UBr. J. Pharmacol. (PubMed) (Umnqamlezo) Ngo-1999; 128: 149-157. Jonga i-abstract.
  143. UCiolino, H. P. kunye no-Yeh, G. C. Inhibition ye-aryl hydrocarbon-indased cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Umol. IPharmacol. Ngo-1999; 56: 760-767. Jonga i-abstract.
  144. I-Lin, J. K. kunye ne Tsai, S. H. Chemoprevention yomhlaza kunye nesifo sentliziyo yi-resveratrol. Inkqubo yeNatl.Sci Council.Repub. China B 1999; 23: 99-106. Jonga i-abstract.
  145. UZou, J. G., Huang, Y. Z., Chen, Q., Wei, E.H, Hsieh, T., noWu, J. M.Resveratrol inqanda ubhedu lwe-ion-indened kunye ne-azo eyenziweyo yokuguqulwa kwe-oxidative ye-lipoprotein ephantsi yabantu. Ibhayoloji. UMol. Biol. Int. Ngo-1999; 47: 1089-1096. Jonga i-abstract.
  146. URahman, I. Inkqubela phambili yonyango kwi-COPD. Ther.Adv.Ukucebisa. Ngo-2008; 2: 351-374. Jonga i-abstract.
  147. UKimura, Y., Okuda, H., kunye noKubo, M. Iziphumo ze-stilbenes ezizimeleyo kwizityalo zonyango kwi-arachidonate metabolism kunye ne-degranulation kwi-polymorphonuclear leukocytes yabantu. J U-Ethnopharmacol. 1995; 45: 131-139. Jonga i-abstract.
  148. UTome-Carneiro, J., Gonzalvez, M., Larrosa, M., Garcia-Almagro, FJ, Aviles-Plaza, F., Parra, S., Yanez-Gascon, MJ, Ruiz-Ros, JA, Garcia-Conesa , MT, Tomas-Barberan, FA, kunye ne-Espin, JC Ukusetyenziswa kwesongezelelo somdiliya esine-resveratrol kunciphisa i-LDL ene-oxidized kunye ne-ApoB kwizigulana ezenziwa kuthintelo oluphambili lwesifo sentliziyo: -imfama kathathu, ukulandela inyanga-ezi-6, i-placebo , ulingo olungenamsebenzi. I-Mol. Nutrut yokutya Res 2012; 56: 810-821. Jonga i-abstract.
  149. UTome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, MJ, Garcia-Almagro, FJ, Ruiz-Ros, JA, Garcia-Conesa, MT, Tomas-Barberan, FA, kunye no-Espin, I-JC yokusetyenziswa konyaka omnye kwe-nutraceutical yomdiliya ene-resveratrol iphucula imeko yokuvuvukala kunye ne-fibrinolytic yezigulana kuthintelo lokuqala lwesifo sentliziyo. NdinguJ Cardiol. 8-1-2012; 110: 356-363. Jonga i-abstract.
  150. I-Zern, TL, Wood, RJ, Greene, C., West, KL, Liu, Y., Aggarwal, D., Shachter, NS, noFernandez, ML Iipolyphenols zediliya zenza isiphumo se-cardioprotective kubasetyhini abangaphambi kunye nabasemva kwe-postmenopausal ngokunciphisa iplasma. lipids kunye nokunciphisa uxinzelelo lwe-oxidative. J Isondlo. 2005; 135: 1911-1917. Jonga i-abstract.
  151. Piver, B., Berthou, F., Dreano, Y., kunye noLucas, D. Umahluko wokwahlula i-cytochrome yabantu i-P450 enzymes yi-epsilon-viniferin, i-dimer ye-resveratrol: ukuthelekisa kunye ne-resveratrol kunye neepolyphenols ezivela kwiziselo ezinxilisayo. Inzululwazi yoBomi. 7-18-2003; 73: 1199-1213. Jonga i-abstract.
  152. de, Santi C., Pietrabissa, A., Mosca, F., kunye nePacifici, G. M. Glucuronidation ye-resveratrol, imveliso yendalo ekhoyo kwiidiliya nakwiwayini, kwisibindi somntu. Xenobiotica 2000; 30: 1047-1054. Jonga i-abstract.
  153. URosa, F. T., Zulet, M. A., Marchini, J. S., kunye noMartinez, J. A. Bioactive iikhompawundi ezineziphumo zokumakisha kubantu. I-Int J yokutya iSci Nutriti 2012; 63: 749-765. Jonga i-abstract.
  154. U-Chang, u-T., U-Chen, u-J no-Lee u-W. B. Umahluko kuthintelo kunye nokungasebenzi kwe-enzymes ye-CYP1 ye-trans-resveratrol: ubungqina bendlela esekwe ekusebenzeni kwe-CYP1A2. UJ. Pharmacol, Isihlomelo. 2001; 299: 874-882. Jonga i-abstract.
  155. Ngokusisiseko, J. P., Marre-Fournier, F., Le Bail, J. C., Habrioux, G., kunye noChulia, A. J. Estrogenic / antiestrogenic kunye nokuchitha iipropathi (E) - kunye (Z) -resveratrol. Inzululwazi yoBomi. 1-21-2000; 66: 769-777. Jonga i-abstract.
  156. UMueller SO, uSimon S, uChae K, et al. I-Phytoestrogens kunye ne-metabolites yazo yabantu zibonisa iipropathi ezahlukileyo ze-agonistic kunye ne-antagonistic kwi-estrogen receptor alpha (ERalpha) kunye ne-ERbeta kwiiseli zabantu. Ityhefu yePhepha 2004; 80: 14-25. Jonga i-abstract.
  157. UBoocock DJ, uFaust GE, uPatel KR, et al. Isigaba I idosi yokunyuka kwesifundo se-pharmacokinetic kumavolontiya asempilweni e-resveratrol, iarhente yokufumana umhlaza enokubakho. Umhlaza we-Epidemiol Biomarkers Prev 2007; 16: 1246-52. Jonga i-abstract.
  158. ILyon MM, Yu C, Toma RB, et al. I-Resveratrol kwi-blueberries eluhlaza kunye neebhaki. J Agric Ukutya Chem 2003; 51: 5867-70. Jonga i-abstract.
  159. I-Trincheri NF, uNicotra G, uFollo C, et al. I-Resveratrol inciphisa ukufa kweseli kwiiseli zomhlaza ezinobungqingqwa ngendlela yenoveli ebandakanya i-lysosomal cathepsin D. Carcinogenesis 2007; 28: 922-31. Jonga i-abstract.
  160. UScarlatti F, uSala G, uSomenzi G, et al. I-Resveratrol induces ukukhula kwe-inhibition kunye ne-apoptosis kwiiseli zomhlaza webele we-metastatic nge-de novo ceramide signaling. I-FASEB J 2003; 17: 2339-41. Jonga i-abstract.
  161. UWang Q, uLi H, uWang XW, et al. I-Resveratrol ikhuthaza umahluko kwaye inyusa i-Fas-ezimeleyo ye-apoptosis yeeseli ze-medulloblastoma yomntu. I-Neurosci Lett 2003; 351: 83-6. Jonga i-abstract.
  162. ICulpitt SV, iRogers DF, iFenwick PS, et al. Ukuthintela ukukhutshwa kwewayini ebomvu, i-resveratrol, yokukhululwa kwe-cytokine yi-alveolar macrophages kwi-COPD. I-Thorax 2003; 58: 942-6. Jonga i-abstract.
  163. I-Pervaiz S. Resveratrol: ukusuka kwiidiliya ukuya kwi-biology ye-mammalian. I-FASEB J 2003; 17: 1975-85. Jonga i-abstract.
  164. USavaskan E, uOlivieri G, uMeier F, et al. Isithako sewayini ebomvu i-resveratrol ikhusela kwi-beta-amyloid neurotoxicity. IGerontology 2003; 49: 380-3. Jonga i-abstract.
  165. UGao X, uDeeb D, iMedia J, et al. Umsebenzi we-immunomodulatory we-resveratrol: ukungafani kwi-vitro kunye ne-vivo ye-immunological. Biochem Pharmacol 2003; 66: 2427-35. Jonga i-abstract.
  166. ISchriever C, iPendland SL, iMahady GB. Iwayini ebomvu, i-resveratrol, iChlamydia pneumoniae kunye nonxibelelwano lwaseFrance. I-Atherosclerosis 2003; 171: 379-80. Jonga i-abstract.
  167. IZiegler CC, Amanzi emvula L, uWhelan J, McEntee MF. I-resveratrol yokutya ayichaphazeli i-tumorigenesis yamathumbu emathunjini kwiigundane ze-Apc (Min / +). J Amanqatha 2004; 134: 5-10. Jonga i-abstract.
  168. UKim YA, uChoi BT, uLee YT, et al. I-Resveratrol inqanda ukwanda kweseli kwaye inciphisa i-apoptosis yesifo somntu webele se-carcinoma i-MCF-7. U-Oncol Rep 2004; 11: 441-6. Jonga i-abstract.
  169. UZhang Y, uJayaprakasam B, uSeeram NP, et al. Ukufihlwa kwe-insulin kunye ne-cyclooxygenase enzyme inhibition yi-cabernet sauvignon yomdiliya wekhompawundi. J Agric Ukutya Chem 2004; 52: 228-33. Jonga i-abstract.
  170. I-Opipari AW Jr, Tan L, Boitano AE, et al. I-Resveratrol-indased autophagocytosis kwiiseli zomhlaza we-ovari. Umhlaza Res 2004; 64: 696-703. Jonga i-abstract.
  171. I-Abou-Zeid LA, i-El-Mowafy AM. Ukwahlula okwahlukileyo kwee-resveratrol isomers yi-estrogen receptor-alpha yomntu: ubungqina beemolekyuli zobungqina bokubopha kwe-ligand stereoselective. Ukuziphatha kakubi ngo-2004; 16: 190-5. Jonga i-abstract.
  172. UMeng X, uMaliakal P, uLu H, et al. Amanqanaba e-Urinary kunye neplasma ye-resveratrol kunye ne-quercetin ebantwini, kwiimpuku, nakwiigundane emva kokungenisa iikhompawundi ezihlambulukileyo kunye nejusi yomdiliya. J Agric Ukutya Chem 2004; 52: 935-42. Jonga i-abstract.
  173. IHascalik S, uCelik O, iTurkoz Y, et al. I-Resveratrol, iwayini ebomvu i-polyphenol, ikhusela kumonakalo we-ischemia-reperfusion of the ovaries. Utyalo-mali lweGynecol Obstet 2004; 57: 218-23. Jonga i-abstract.
  174. UAhmad KA, uClement MV, uHanif IM, uPervaiz S.I-Resveratrol inhibits apoptosis ebangelwa ziziyobisi kwiiseli ze-leukemia yabantu ngokwenza i-intracellular milieu non -ermissive for death death. Umhlaza Res 2004; 64: 1452-9. Jonga i-abstract.
  175. U-Li W, u-Seifert M, u-Xu Y, u-Hock B. Uvavanyo lokuthelekisa amandla e-estrogenic e-estradiol, i-tamoxifen, i-bisphenol-A kunye ne-resveratrol ene-in vitro bioassays ezimbini. Indawo yangaphakathi 2004; 30: 329-35. Jonga i-abstract.
  176. UMartin AR, uVillegas I, uLa Casa C, waseLastra CA. I-Resveratrol, ipolyphenol efumaneka kwiidiliya, icinezela umonakalo we-oxidative kwaye ivuselele i-apoptosis ngexesha lokuqala kokudumba kweekolon kwiigundane. Biochem Pharmacol 2004; 67: 1399-410. Jonga i-abstract.
  177. Szewczuk LM, Forti L, Stivala LA, uPenning TM.I-Resveratrol yi-peroxidase Mediated inactivator ye-COX-1 kodwa hayi i-COX-2: Indlela yoomatshini kuyilo lweearhente ezikhethiweyo ze-COX-1. J Biol Chem 2004; 279: 22727-37. Jonga i-abstract.
  178. UWang Z, uHuang Y, uZou J, et al. Iziphumo zewayini elibomvu kunye newayini ye-polyphenol resveratrol kwiflatelet aggregation kwi-vivo nakwi-vitro. I-Int J Mol Med 2002; 9: 77-9. Jonga i-abstract.
  179. UMokni M, uLimam F, uElkahoui S, et al. Isiphumo esomeleleyo se-cardioprotective ye-resveratrol, iwayini ebomvu i-polyphenol, kwiintliziyo ezizimeleyo zentliziyo emva kokulimala kwe-ischemia / reperfusion. IArch Biochem Biophys 2007; 457: 1-6. Jonga i-abstract.
  180. U-Elmali N, uBaysal O, uHarma A, okqhubekayo. Iziphumo ze-resveratrol kwisifo sokuqaqamba kwamalungu. Ukudumba 2007; 30: 1-6. Jonga i-abstract.
  181. Bujanda L, Garcia-Barcina M, Gutierrez-de Juan V, okqhubekayo. Iziphumo ze-resveratrol kukufa okubangelwa butywala kunye nezilonda zesibindi kwiimpuku. I-BMC Gastroenterol 2006; 6:35. Jonga i-abstract.
  182. IBaur JA, Pearson KJ, Ixabiso leNL, et al. I-Resveratrol iphucula impilo kunye nokusinda kweempuku kukutya okuphezulu kweekhalori. Uhlobo 2006; 444: 337-42. Jonga i-abstract.
  183. UMurias M, uMphathi weN, uNerker T, et al. I-Resveratrol analogue njenge-cyclooxygenase-2 inhibitors ekhethiweyo: ubudlelwane bokuqala kunye nolwalamano lomsebenzi. I-Bioorg Med Chem 2004; 12: 5571-8. Jonga i-abstract.
  184. UHwang D, uFischer NH, uJang BC, et al. Ukuthintela ukubonakaliswa kwe-cyclooxygenase engafakwanga kunye ne-cytokines proinfigueatory yi-sesquiterpene lactones kwii-macrophages ezihambelana nokuthintela i-MAP kinases. I-Biochem Biophys Res Commun 1996; 226: 810-8 .. Jonga okungafakwanga.
  185. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Ii-nonsteroidal anti-inflammatory agents ziyahluka ngokwamandla abo okucinezela ukusebenza kwe-NF-kappaB, ukuthintela ukubonakaliswa kwe-cyclooxygenase-2 kunye ne-cyclin D1, kunye nokuchithwa kwesisu se-tumor. I-Oncogene 2004; 23: 9247-58. Jonga i-abstract.
  186. IGoldberg DM, uYan J, uSoleas GJ. Ukufunxa iipolyphenol ezintathu ezinxulumene newayini kwimatriki ezintathu ezahlukeneyo ngezifundo ezisempilweni. Iiklinikhi ye-Biochem 2003; 36: 79-87 .. Jonga i-abstract.
  187. Uxwebhu JJ, Fu MM, Stiffler BS, et al. I-Resveratrol inhibition yokuphindaphindeka kwentsholongwane ye-herpes. Intsholongwane ka-1999; 43: 145-55. Jonga i-abstract.
  188. IBowers JL, iTyulmenkov VV, iJernigan SC, iKlinge CM. I-Resveratrol isebenza njenge-agonist / antagonist edibeneyo ye-estrogen receptors alpha kunye ne-beta. I-Endocrinology 2000; 141: 3657-67.
  189. Piver B, Berthou F, Dreano Y, Lucas D. Ukuthintela imisebenzi ye-CYP3A, CYP1A kunye ne-CYP2E1 ngokwenza i-resveratrol kunye nezinye izinto zewayini ebomvu ezingazinzanga. I-Toxicol Lett 2001; 125: 83-91. Jonga i-abstract.
  190. ILaden BP, iPorter TD. I-Resveratrol inhibits yabantu squalene monooxygenase. Ukutya okunesondlo 2001; 21: 747-53.
  191. I-Kozuki Y, i-Miura Y, i-Yagasaki K. I-Resveratrol icinezela uhlaselo lweeseli ze-hepatoma ngaphandle kwesenzo sayo sokulwa nokwanda. Jonga i-abstract.
  192. USchneider Y, uVincent F, uDuranton B, et al. Isiphumo sokuchasana nokwanda kwe-resveratrol, into yendalo yeediliya kunye newayini, kwiiseli zomhlaza zekolonic zabantu. Umhlaza Lett 2000; 158: 85-91.
  193. UJacobson JS, uTroxel AB, uEvans J, et al. Uvavanyo olungahleliwe lwe-cohosh emnyama kunyango olushushu phakathi kwabasetyhini abanembali yomhlaza webele. J Ikliniki yase-Oncol 2001; 19: 2739-45. Jonga i-abstract.
  194. IHolmes-McNary M, Baldwin AS, Jr.Iipropathi zokuthintela ukwenziwa kwe-trans-resveratrol zinxulunyaniswa nokuthintela ukwenziwa kwe-IkappaB kinase. Umhlaza Res 2000; 60: 3477-83. Jonga i-abstract.
  195. UBertelli AA, uGiovannini L, uGiannessi D, et al. Umsebenzi we-Antiplatelet we-synthetic and resveratrol yendalo kwiwayini ebomvu. I-Int J Tissue React 1995; 17: 1-3. Jonga i-abstract.
  196. UGehm BD, uMcAndrews JM, uChien PY, uJameson JL. I-Resveratrol, ikhompawundi ye-polyphenolic efumaneka kwiidiliya nakwiwayini, yi-agonist ye-estrogen receptor. Iproc Natl Acad Sci U S A 1997; 94: 14138-43. Jonga i-abstract.
  197. UCarbo N, uCostelli P, uBaccino FM, et al. I-Resveratrol, imveliso yendalo ekhoyo kwiwayini, inciphisa ukukhula kwethumba kwimodeli ye-rat tumor. I-Biochem Biophys Res Commun 1999; 254: 739-43. Jonga i-abstract.
  198. IHuang C, Ma WY, iGoranson A, iDong Z.I-Resveratrol icinezela inguquko yeseli kwaye inyanzelisa i-apoptosis ngendlela exhomekeke kwi-p53. ICarcinogenesis 1999; 20: 237-42. Jonga i-abstract.
  199. UDavy BM, uMelby CL, uBeske SD, et al. Ukusetyenziswa kwe-oat akuchaphazeli ukuphumla okungafunekiyo kunye nokuhamba koxinzelelo lwegazi lwe-24-h kumadoda anexinzelelo oluphezulu lwegazi ukuya kwinqanaba Ixinzelelo lwegazi. J Nutriti 2002; 132: 394-8 .. Jonga okungafakwanga.
  200. I-Chen CK, iPace-Asciak CR. Umsebenzi weVasorelaxing we-resveratrol kunye ne-quercetin kwi-rat aorta eyahlukileyo. IGen Pharmacol 1996; 27: 363-6. Jonga i-abstract.
  201. UBertelli A, uBertelli AA, uGozzini A, uGiovannini L.Plasma kunye neethishu zokugxininisa kwizicubu kunye nomsebenzi weyeza. Iziyobisi kwiKlinikhi yokuHamba ngo-1998; 24: 133-8. Jonga i-abstract.
  202. Isantya-Asciak CR, Hahn S, Diamandis EP, et al. Iwayini ebomvu i-phenolics trans-resveratrol kunye ne-quercetin ibhloko yeplatelet yabantu kunye ne-eicosanoid synthesis: iimpembelelo zokukhusela kwisifo sentliziyo. Iiklinikhi zeChim Acta 1995; 235: 207-19. Jonga i-abstract.
  203. UBertelli AA, uGiovannini L, uBernini W, et al. Umsebenzi we-Antiplatelet we-cis-resveratrol. Iziyobisi kwiKlinikhi yokuHamba ngo-1996; 22: 61-3. Jonga i-abstract.
  204. Isantya-Asciak CR, uRounova O, Hahn SE, et al. Iiwayini kunye neencindi zeediliya njengeemodyuli zokudityaniswa kweplatelet kwizifundo ezisempilweni zabantu. Iiklinikhi zeChim Acta 1996; 246: 163-82. Jonga i-abstract.
  205. UJang M, uCai L, Udeani GO, et al. Umsebenzi weCancer chemopreventive we-resveratrol, imveliso yendalo evela kwiidiliya. Inzululwazi 1997; 275: 218-20. Jonga i-abstract.
  206. I-Soleas GJ, iDiamandis EP, iGoldberg DM. I-Resveratrol: imolekyuli yexesha lifikile? Kwaye uhambe? Iiklinikhi zeBiochem 1997; 30: 91-113. Jonga i-abstract.
  207. I-Agri Res Svc: Ugcino lukaDkt.Duke's phytochemical kunye ethnobotanical database. www.ars-grin.gov/duke (Ifumaneka nge-3 Novemba 1999).
  208. Uphengululo lweeMveliso zeNdalo ngamaNqaku kunye nokuThelekisa. ILouis, MO: iWolters Kluwer Co., 1999.
  209. Foster S, uTyler VE. I-Herbal ethembekileyo yeTyler: Isikhokelo esiSebenzisayo sokuSebenzisa iiHerbs kunye neZonyango ezinxulumene noko. I-3rd ed., IBinghamton, NY: I-Haworth Herbal Press, ngo-1993.
  210. INewall CA, uAnderson LA, uPhilpson JD. Unyango ngamayeza esintu: Isikhokelo saBasebenzi bezeMpilo. ILondon, e-UK: Icandelo leendaba lonyango, ngo-1996.
  211. UTyler VE. IiHerbs zoKhetho. I-Binghamton, NY: Imveliso yezeMveliso yezeMveliso, ngo-1994.
  212. Blumenthal M, ed. IKhomishini epheleleyo yaseJamani i-E Monographs: Isikhokelo sonyango kumaYeza eHerbal. Dlulisa. S. Klein. IBoston, MA: IBhunga laseMelika leBhotani, i-1998.
  213. Monographs ekusebenziseni amayeza iziyobisi zezityalo. I-Exeter, e-UK: I-European Scientific Co-op Phytother, ngo-1997.
Ukuhlaziywa kokugqibela-09/30/2020

Isabelo

Unyango lokunyanga uMhlaza weMole
Zempilo

Unyango lokunyanga uMhlaza weMole

Unyango lomhlaza othambileyo, o i ifo e idluli elwa ngeentlobano ze ini, kufuneka ukhokelwe ngugqirha womchamo, kwimeko yamadoda, okanye ugqirha wezifo zaba etyhini, kwimeko yaba etyhini, kodwa ihlala...
I-Fluoxetine -Uthatha njani kunye neempembelelo zecala
Zempilo

I-Fluoxetine -Uthatha njani kunye neempembelelo zecala

I-Fluoxetine i idambi i omlomo e ifumaneka ngohlobo lwe-10 mg okanye iipili i ezingama-20 mg okanye ngamathont i, kwaye inoku etyenzi elwa ukunyanga i-bulimia nervo a.I-Fluoxetine i iyobi i e ifana ne...